Inventor · disambiguated record
Kuninori Tai
Also filed as: TAI KUNINORI
17 granted patents·3 pending applications·101 citations·filing 1999–2020
92Inventor score
Top patents by PatentIndex Score
20 records- 0189US7262212B22,3-dihydro-6-nitroimidazo[2,1-b]oxazolesOTSUKA PHARMA CO LTD·Filed 2003·Granted Aug 28, 2007·56 cites·50 claims
- 0283US8822453B2Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillationMATSUMURA SHUUJI·Filed 2010·Granted Sep 2, 2014·18 cites·11 claims
- 0382US10000450B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2017·Granted Jun 19, 2018·3 cites·6 claims
- 0479US8084442B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2006·Granted Dec 27, 2011·4 cites·9 claims
- 0578US8815871B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2013·Granted Aug 26, 2014·3 cites·6 claims
- 0678US8420623B2N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2011·Granted Apr 16, 2013·4 cites·10 claims
- 0777US10603331B2Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamineOTSUKA PHARMA CO LTD·Filed 2018·Granted Mar 31, 2020·1 cites·5 claims
- 0876US8188277B2Aromatic compounds for suppressing the generation of collagenFUKUSHIMA TAE·Filed 2005·Granted May 29, 2012·6 cites·14 claims
- 0971US11273168B2Methods of treating anxiety by administering a substituted quinoloneOTSUKA PHARMA CO LTD·Filed 2020·Granted Mar 15, 2022·0 cites·6 claims
- 1064US10626095B2Cyanotriazole compoundsOTSUKA PHARMA CO LTD·Filed 2014·Granted Apr 21, 2020·1 cites·11 claims
- 1162US2018258038A1N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1260US10064879B2Method for treating depression and/or depression status with substituted quinoxaline compoundsOTSUKA PHARMA CO LTD·Filed 2017·Granted Sep 4, 2018·0 cites·7 claims
- 1360US9611214B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2014·Granted Apr 4, 2017·0 cites·7 claims
- 1457US9051333B26,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericidesKAWANO YOSHIKAZU·Filed 2012·Granted Jun 9, 2015·1 cites·9 claims
- 1556US9090572B2Substituted quinoxalines compoundsITO NOBUAKI·Filed 2011·Granted Jul 28, 2015·0 cites·7 claims
- 1654US2016058757A1Heterocyclic compounds for treating or preventing disorers caused by reduced neurotransmission of serotonin, norephnephrine or dopamineOTSUKA PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 1750US8338406B2Benzodiazepine compound and pharmaceutical compositionOSHIMA KUNIO·Filed 2009·Granted Dec 25, 2012·0 cites·7 claims
- 1850US6333431B1Processes for the preparation of fluorinated benzoic acidsOTSUKA PHARMA CO LTD·Filed 1999·Granted Dec 25, 2001·4 cites·18 claims
- 1941US8664217B2Benzodiazepine compound and pharmaceutical compositionOSHIMA KUNIO·Filed 2012·Granted Mar 4, 2014·0 cites·2 claims
- 2040US2012238750A1Aromatic compoundFUKUSHIMA TAE·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →